Hap Trading, LLC Aeterna Zentaris Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.17 - $0.37 $1,547 - $3,367	-9,100 Reduced 43.75%	11,700 $1,000
Q1 2022 May 12, 2022	BUY	$0.33 - $0.42 $693 - $882	2,100 Added 11.23%	20,800 $1,000
Q4 2021 Feb 14, 2022	SELL	$0.36 - $0.77 $1,980 - $4,235	-5,500 Reduced 22.73%	18,700 $1,000
Q3 2021 Nov 10, 2021	SELL	$0.59 - $0.88 $4,484 - $6,688	-7,600 Reduced 23.9%	24,200 $7,000
Q2 2021 Aug 11, 2021	SELL	$0.83 - $1.14 $830 - $1,140	-1,000 Reduced 3.05%	31,800 $3,000
Q1 2021 May 14, 2021	BUY	$0.51 - $3.34 $16,728 - $109,552	32,800 New	32,800 $7,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.